-
What Investors Need To Know On Heels Of Tilray's Q1 Earnings Release
Friday, October 8, 2021 - 8:51am | 718Read More...On Thursday, Tilray, Inc. (NASDAQ: TLRY) (TSX: TLRY) released its financial results for the first fiscal quarter ended August 31, 2021, revealing net revenue of $168 million, up by 43% year-over-year and below the consensus estimates of $174.93 million. Based in New York and Ontario, the company...
-
Valeant's Guidance Looks Conservative
Tuesday, February 28, 2017 - 10:02am | 301Read More...Valeant Pharmaceuticals Intl Inc (NYSE: VRX) reported its Q4 2016 results in-line with expectations, but guidance for 2017 short of the consensus estimates. “We believe this guidance is likely conservative based on the pacing on expected genericizations,” RBC Capital Markets’...
-
RBC Cuts Valeant Valuation In Half, Downgrades Because Of SEC Probe
Tuesday, March 1, 2016 - 10:38am | 236Read More...RBC Capital Markets' Douglas Miehm downgraded the rating for Valeant Pharmaceuticals Intl Inc (NYSE: VRX) from Outperform to Sector Perform, while reducing the price target from $194 to $85. Valeant announced that it is facing several ongoing investigations, including those by the US Attorney's...
-
RBC Upgrades Shire To Outperform, Says Market Overestimating Competition
Wednesday, February 10, 2016 - 11:45am | 229Read More...Shares of Shire PLC (ADR) (NASDAQ: SHPG) have plummeted 25 percent since January 4. RBC Capital Markets’ Douglas Miehm upgraded the rating on the company from Sector Perform to Outperform, with a price target of $240. The recent decline in stock more than accounts for any...
-
Concordia Healthcare Fell More Than Its Peers...But These Analysts Think It's Coming Back
Thursday, October 1, 2015 - 4:18pm | 376Read More...RBC resumed coverage of Concordia Healthcare Corp (NASDAQ: CXRX) with an Outperform rating and $86.00 price target on Wednesday. According to a report issued Wednesday, the substantial decline in the company’s stock price is unwarranted. Shares of Concordia Healthcare are down roughly 1...
